Viewing data from:

FARYDAK

NDA

PANOBINOSTAT LACTATE | N205353 | SECURA BIO INC

3 strengths2 unique patents0 unique exclusivities

Patent Timeline

2 unique patents by expiration date

Active (2)Today

2027

2028

Today

7989494

Jan. 17, 2028

8883842

Jun. 13, 2028

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

API Supply Chain1 active DMF

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

MSN LABORATORIES PRIVATE LTDPANOBINOSTAT LACTATE

DMF 326592018

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

2 letters from Drugs@FDA

Date	Submission	Document
Jun 8, 2016	SUPPL -1	View Letter (PDF)
Feb 24, 2015	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (3)

Sort:

#001 — EQ 10MG BASE

RLD

2 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Feb 23, 2015

Patents (2)

Patent #	Expiration	PED	Drug Substance	Drug Product	Use Code	Delist
7989494	Jan 17, 2028	—	Yes	Yes	—	—
8883842	Jun 13, 2028	—	—	—		—

#002 — EQ 15MG BASE

RLD

2 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Feb 23, 2015

#003 — EQ 20MG BASE

RLD

2 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Feb 23, 2015